CCL14 and neoplasm: Notably, increased CCL14 expression was significantly correlated with tumor status (T2, Stage III and Stage IV vs. Stage I, OR = 0.681, 95% CI = 0.484–0.958, P = 0.028), sex (male vs. female, OR = 0.681, 95% CI = 0.484–0.958, P = 0.028), and earlier pathological stage (T2, T3 and T4 vs. T1; OR = 0.459, 95% CI = 0.315–0.663, P < 0.001).